GlassScriptPhysician profile
Mandy L Woods
NPI 1184486375
$1,163.63
in general payments reported to CMS, 2019-2025
10 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,045 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $746 · Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $745.72 |
| Food and Beverage | $417.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $943.97 | 2024 | Iovera, Zilretta, Exparel |
| Organogenesis INC. | $74.32 | 2024 | Affinity |
| Averitas Pharma INC. | $28.50 | 2024-2025 | Qutenza |
| Pharming Healthcare, INC. | $22.42 | 2025 | Ruconest |
| Paratek Pharmaceuticals, INC. | $18.14 | 2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $17.12 | 2025 | Keytruda |
| Astellas Pharma US INC | $16.43 | 2025 | Padcev |
| Bioventus LLC | $15.65 | 2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $13.96 | 2025 | |
| Conetic Solutions, INC. | $13.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.